0

Close
 
Upcoming Allied Market Research
2023
Cell Separation Market

Cell Separation Market

by Product Type (Consumables, Instruments), by Cell Type (Human Cells, Animal Cells), by Technique (Centrifugation, Surface Marker, Filtration), by Application (Research Laboratories and Institutes, Biotechnology and Biopharmaceutical Companies, Others) and by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals
Report Code: A13859
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cell Separation Market

Request Now !

Cell separation is the process of removing one cell population from another within a biological sample, such as blood or tissue. Different technologies are used to isolate cell populations. These technologies are based on one or more properties unique to the targeted cell type—such as size, density, electric charge, shape, or protein expression—to label those cells for removal. They include fluorescence-activated cell sorting (FACS), density gradient centrifugation, and magnetic-activated cell sorting (MACS).
Cell separation plays an important role in various applications, including biologics designing & development, therapeutic protein production, in-vitro diagnostics, and other research applications such as capture circulating tumor cells in the blood, conduct molecular analysis of specific cell populations, isolate immune cells from peripheral blood, preparing a sample of blood separated from plasma, separate bacteria from food, study the effects of drug candidates on cell types, isolate white blood cells from tissue, recover mononucleated cells from the blood.

COVID-19 Impact analysis

  • The COVID-19 pandemic disturbed the entire supply chain in the majority of industries worldwide. However, the COVID-19 pandemic has created a lucrative opportunity for researchers to study and understand this new infectious virus to develop treatments and diagnostic tools for it. Several pharmaceutical and biotech giants have been conducting rapid and extensive R&D activities to develop novel vaccines, therapies, and testing kits by using stem cells or regenerative medicine. This has significantly boosted the demand for cell separation tools in research applications. 
  • The governing board of the California Institute for Regenerative Medicine (CIRM) approved USD 5 million in funding for peer-reviewed regenerative medicine and stem cell research that could quickly develop treatments for COVID-19. Stem Cell Network (SCN) is providing up to USD 500,000 in funding to support rapid response research that uses a stem cell or regenerative medicine approach for addressing COVID-19.

Top Impacting Factors
Increasing number of patients suffering from cancer and infectious diseases (COVID-19) is the major factor responsible for the growth of this market.
In addition, increasing government funding for cell-based research, growing focus on personalized medicine, and technological advancements are likely to propel the market growth. 
Increasing investments in cell biology research and the growing presence of market players in developing countries are the key factors responsible for the high growth of the cell isolation market.
Due to increasing R&D activities in the pharmaceutical and biotechnology industries, the adoption of several advanced equipment and methodologies is expected to increase market growth.
However, cell separation techniques encompass a wide range of costs involving instruments, reagents, kits, sera, and services. The reagents used for specific applications are of high cost and cell separation setup is expensive. These factors are anticipated to hinder the growth of the market during the forecast period.
Market Trends
New product launches to flourish the market

  • In May 2019, Thermo Fisher Scientific acquired Brammer Bio with the aim to expand capabilities to support the high growth gene and cell therapy market. Both companies announced that they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately $1.7 billion in cash. By leveraging their combined capabilities, along with commercial scale and customer relationships, this will strengthen their position as a trusted partner to pharma and biotech to make more life-saving treatments available to patients.
  • In October 2018, Merck opened its M Lab Collaboration Center in São Paulo, the new collaboration center to provide support from pre-clinical through full-scale production in a non-GMP environment. In addition, it provides hands-on customer access to Merck’s product portfolio and technical expertise.
  • In May 2019, Beckman Coulter launched ClearLLab 10C System.

Surge in usage in chronic diseases

  • According to the WHO, cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in the year 2018. Globally, about 1 in 6 deaths is due to cancer disease. Approximately 70% of deaths from cancer disease occur in low- and middle-income countries. Therefore, the increasing prevalence of chronic diseases and technological advancement and innovation in cell isolation are the key driving factors in the cell isolation market.

Key Benefits of the Report

  • This study presents the analytical depiction of the cell separation along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the cell separation market share.
  • The current market is quantitatively analyzed to highlight the cell separation market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed cell separation market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Cell Separation Report

  • Who are the leading market players active in the cell separation market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "cell separation "?
  • What is "cell separation " market prediction in the future?
  • Who are the leading global players in the "cell separation " market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "cell separation " market report?

 Cell Separation Market Report Highlights

Aspects Details
By Product Type
  • Consumables
  • Instruments
By Cell Type
  • Human Cells
  • Animal Cells
By Technique
  • Centrifugation
  • Surface Marker
  • Filtration
By Application
  • Research Laboratories and Institutes
  • Biotechnology and Biopharmaceutical Companies
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players STEMCELL Technologies Inc., Bio-Rad Laboratories Inc, Merck KgaA, Terumo BCT, PluriSelect Life Science UG & Co. KG, MiltenyiBiotec, Becton Dickinson and Company, Thermo Fisher Scientific, Beckman Coulter, Inc., GE Healthcare
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CELL SEPARATION MARKET, BY PRODUCT TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product Type

    • 4.2. Consumables

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Instruments

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: CELL SEPARATION MARKET, BY CELL TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Cell Type

    • 5.2. Human Cells

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Animal Cells

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: CELL SEPARATION MARKET, BY TECHNIQUE

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Technique

    • 6.2. Centrifugation

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Surface Marker

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Filtration

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: CELL SEPARATION MARKET, BY APPLICATION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Application

    • 7.2. Research Laboratories And Institutes

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Biotechnology And Biopharmaceutical Companies

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Others

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: CELL SEPARATION MARKET, BY END USER

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By End User

    • 8.2. Hospitals

      • 8.2.1. Key Market Trends, Growth Factors and Opportunities

      • 8.2.2. Market Size and Forecast, By Region

      • 8.2.3. Market Share Analysis, By Country

    • 8.3. Ambulatory Surgical Centers

      • 8.3.1. Key Market Trends, Growth Factors and Opportunities

      • 8.3.2. Market Size and Forecast, By Region

      • 8.3.3. Market Share Analysis, By Country

    • 8.4. Others

      • 8.4.1. Key Market Trends, Growth Factors and Opportunities

      • 8.4.2. Market Size and Forecast, By Region

      • 8.4.3. Market Share Analysis, By Country

  • CHAPTER 9: CELL SEPARATION MARKET, BY REGION

    • 9.1. Market Overview

      • 9.1.1 Market Size and Forecast, By Region

    • 9.2. North America

      • 9.2.1. Key Market Trends and Opportunities

      • 9.2.2. Market Size and Forecast, By Product Type

      • 9.2.3. Market Size and Forecast, By Cell Type

      • 9.2.4. Market Size and Forecast, By Technique

      • 9.2.5. Market Size and Forecast, By Application

      • 9.2.6. Market Size and Forecast, By End User

      • 9.2.7. Market Size and Forecast, By Country

      • 9.2.8. U.S. Cell Separation Market

        • 9.2.8.1. Market Size and Forecast, By Product Type
        • 9.2.8.2. Market Size and Forecast, By Cell Type
        • 9.2.8.3. Market Size and Forecast, By Technique
        • 9.2.8.4. Market Size and Forecast, By Application
        • 9.2.8.5. Market Size and Forecast, By End User

      • 9.2.9. Canada Cell Separation Market

        • 9.2.9.1. Market Size and Forecast, By Product Type
        • 9.2.9.2. Market Size and Forecast, By Cell Type
        • 9.2.9.3. Market Size and Forecast, By Technique
        • 9.2.9.4. Market Size and Forecast, By Application
        • 9.2.9.5. Market Size and Forecast, By End User

      • 9.2.10. Mexico Cell Separation Market

        • 9.2.10.1. Market Size and Forecast, By Product Type
        • 9.2.10.2. Market Size and Forecast, By Cell Type
        • 9.2.10.3. Market Size and Forecast, By Technique
        • 9.2.10.4. Market Size and Forecast, By Application
        • 9.2.10.5. Market Size and Forecast, By End User

    • 9.3. Europe

      • 9.3.1. Key Market Trends and Opportunities

      • 9.3.2. Market Size and Forecast, By Product Type

      • 9.3.3. Market Size and Forecast, By Cell Type

      • 9.3.4. Market Size and Forecast, By Technique

      • 9.3.5. Market Size and Forecast, By Application

      • 9.3.6. Market Size and Forecast, By End User

      • 9.3.7. Market Size and Forecast, By Country

      • 9.3.8. France Cell Separation Market

        • 9.3.8.1. Market Size and Forecast, By Product Type
        • 9.3.8.2. Market Size and Forecast, By Cell Type
        • 9.3.8.3. Market Size and Forecast, By Technique
        • 9.3.8.4. Market Size and Forecast, By Application
        • 9.3.8.5. Market Size and Forecast, By End User

      • 9.3.9. Germany Cell Separation Market

        • 9.3.9.1. Market Size and Forecast, By Product Type
        • 9.3.9.2. Market Size and Forecast, By Cell Type
        • 9.3.9.3. Market Size and Forecast, By Technique
        • 9.3.9.4. Market Size and Forecast, By Application
        • 9.3.9.5. Market Size and Forecast, By End User

      • 9.3.10. Italy Cell Separation Market

        • 9.3.10.1. Market Size and Forecast, By Product Type
        • 9.3.10.2. Market Size and Forecast, By Cell Type
        • 9.3.10.3. Market Size and Forecast, By Technique
        • 9.3.10.4. Market Size and Forecast, By Application
        • 9.3.10.5. Market Size and Forecast, By End User

      • 9.3.11. Spain Cell Separation Market

        • 9.3.11.1. Market Size and Forecast, By Product Type
        • 9.3.11.2. Market Size and Forecast, By Cell Type
        • 9.3.11.3. Market Size and Forecast, By Technique
        • 9.3.11.4. Market Size and Forecast, By Application
        • 9.3.11.5. Market Size and Forecast, By End User

      • 9.3.12. UK Cell Separation Market

        • 9.3.12.1. Market Size and Forecast, By Product Type
        • 9.3.12.2. Market Size and Forecast, By Cell Type
        • 9.3.12.3. Market Size and Forecast, By Technique
        • 9.3.12.4. Market Size and Forecast, By Application
        • 9.3.12.5. Market Size and Forecast, By End User

      • 9.3.13. Russia Cell Separation Market

        • 9.3.13.1. Market Size and Forecast, By Product Type
        • 9.3.13.2. Market Size and Forecast, By Cell Type
        • 9.3.13.3. Market Size and Forecast, By Technique
        • 9.3.13.4. Market Size and Forecast, By Application
        • 9.3.13.5. Market Size and Forecast, By End User

      • 9.3.14. Rest Of Europe Cell Separation Market

        • 9.3.14.1. Market Size and Forecast, By Product Type
        • 9.3.14.2. Market Size and Forecast, By Cell Type
        • 9.3.14.3. Market Size and Forecast, By Technique
        • 9.3.14.4. Market Size and Forecast, By Application
        • 9.3.14.5. Market Size and Forecast, By End User

    • 9.4. Asia-Pacific

      • 9.4.1. Key Market Trends and Opportunities

      • 9.4.2. Market Size and Forecast, By Product Type

      • 9.4.3. Market Size and Forecast, By Cell Type

      • 9.4.4. Market Size and Forecast, By Technique

      • 9.4.5. Market Size and Forecast, By Application

      • 9.4.6. Market Size and Forecast, By End User

      • 9.4.7. Market Size and Forecast, By Country

      • 9.4.8. China Cell Separation Market

        • 9.4.8.1. Market Size and Forecast, By Product Type
        • 9.4.8.2. Market Size and Forecast, By Cell Type
        • 9.4.8.3. Market Size and Forecast, By Technique
        • 9.4.8.4. Market Size and Forecast, By Application
        • 9.4.8.5. Market Size and Forecast, By End User

      • 9.4.9. Japan Cell Separation Market

        • 9.4.9.1. Market Size and Forecast, By Product Type
        • 9.4.9.2. Market Size and Forecast, By Cell Type
        • 9.4.9.3. Market Size and Forecast, By Technique
        • 9.4.9.4. Market Size and Forecast, By Application
        • 9.4.9.5. Market Size and Forecast, By End User

      • 9.4.10. India Cell Separation Market

        • 9.4.10.1. Market Size and Forecast, By Product Type
        • 9.4.10.2. Market Size and Forecast, By Cell Type
        • 9.4.10.3. Market Size and Forecast, By Technique
        • 9.4.10.4. Market Size and Forecast, By Application
        • 9.4.10.5. Market Size and Forecast, By End User

      • 9.4.11. South Korea Cell Separation Market

        • 9.4.11.1. Market Size and Forecast, By Product Type
        • 9.4.11.2. Market Size and Forecast, By Cell Type
        • 9.4.11.3. Market Size and Forecast, By Technique
        • 9.4.11.4. Market Size and Forecast, By Application
        • 9.4.11.5. Market Size and Forecast, By End User

      • 9.4.12. Australia Cell Separation Market

        • 9.4.12.1. Market Size and Forecast, By Product Type
        • 9.4.12.2. Market Size and Forecast, By Cell Type
        • 9.4.12.3. Market Size and Forecast, By Technique
        • 9.4.12.4. Market Size and Forecast, By Application
        • 9.4.12.5. Market Size and Forecast, By End User

      • 9.4.13. Thailand Cell Separation Market

        • 9.4.13.1. Market Size and Forecast, By Product Type
        • 9.4.13.2. Market Size and Forecast, By Cell Type
        • 9.4.13.3. Market Size and Forecast, By Technique
        • 9.4.13.4. Market Size and Forecast, By Application
        • 9.4.13.5. Market Size and Forecast, By End User

      • 9.4.14. Malaysia Cell Separation Market

        • 9.4.14.1. Market Size and Forecast, By Product Type
        • 9.4.14.2. Market Size and Forecast, By Cell Type
        • 9.4.14.3. Market Size and Forecast, By Technique
        • 9.4.14.4. Market Size and Forecast, By Application
        • 9.4.14.5. Market Size and Forecast, By End User

      • 9.4.15. Indonesia Cell Separation Market

        • 9.4.15.1. Market Size and Forecast, By Product Type
        • 9.4.15.2. Market Size and Forecast, By Cell Type
        • 9.4.15.3. Market Size and Forecast, By Technique
        • 9.4.15.4. Market Size and Forecast, By Application
        • 9.4.15.5. Market Size and Forecast, By End User

      • 9.4.16. Rest of Asia Pacific Cell Separation Market

        • 9.4.16.1. Market Size and Forecast, By Product Type
        • 9.4.16.2. Market Size and Forecast, By Cell Type
        • 9.4.16.3. Market Size and Forecast, By Technique
        • 9.4.16.4. Market Size and Forecast, By Application
        • 9.4.16.5. Market Size and Forecast, By End User

    • 9.5. LAMEA

      • 9.5.1. Key Market Trends and Opportunities

      • 9.5.2. Market Size and Forecast, By Product Type

      • 9.5.3. Market Size and Forecast, By Cell Type

      • 9.5.4. Market Size and Forecast, By Technique

      • 9.5.5. Market Size and Forecast, By Application

      • 9.5.6. Market Size and Forecast, By End User

      • 9.5.7. Market Size and Forecast, By Country

      • 9.5.8. Brazil Cell Separation Market

        • 9.5.8.1. Market Size and Forecast, By Product Type
        • 9.5.8.2. Market Size and Forecast, By Cell Type
        • 9.5.8.3. Market Size and Forecast, By Technique
        • 9.5.8.4. Market Size and Forecast, By Application
        • 9.5.8.5. Market Size and Forecast, By End User

      • 9.5.9. South Africa Cell Separation Market

        • 9.5.9.1. Market Size and Forecast, By Product Type
        • 9.5.9.2. Market Size and Forecast, By Cell Type
        • 9.5.9.3. Market Size and Forecast, By Technique
        • 9.5.9.4. Market Size and Forecast, By Application
        • 9.5.9.5. Market Size and Forecast, By End User

      • 9.5.10. Saudi Arabia Cell Separation Market

        • 9.5.10.1. Market Size and Forecast, By Product Type
        • 9.5.10.2. Market Size and Forecast, By Cell Type
        • 9.5.10.3. Market Size and Forecast, By Technique
        • 9.5.10.4. Market Size and Forecast, By Application
        • 9.5.10.5. Market Size and Forecast, By End User

      • 9.5.11. UAE Cell Separation Market

        • 9.5.11.1. Market Size and Forecast, By Product Type
        • 9.5.11.2. Market Size and Forecast, By Cell Type
        • 9.5.11.3. Market Size and Forecast, By Technique
        • 9.5.11.4. Market Size and Forecast, By Application
        • 9.5.11.5. Market Size and Forecast, By End User

      • 9.5.12. Argentina Cell Separation Market

        • 9.5.12.1. Market Size and Forecast, By Product Type
        • 9.5.12.2. Market Size and Forecast, By Cell Type
        • 9.5.12.3. Market Size and Forecast, By Technique
        • 9.5.12.4. Market Size and Forecast, By Application
        • 9.5.12.5. Market Size and Forecast, By End User

      • 9.5.13. Rest of LAMEA Cell Separation Market

        • 9.5.13.1. Market Size and Forecast, By Product Type
        • 9.5.13.2. Market Size and Forecast, By Cell Type
        • 9.5.13.3. Market Size and Forecast, By Technique
        • 9.5.13.4. Market Size and Forecast, By Application
        • 9.5.13.5. Market Size and Forecast, By End User

  • CHAPTER 10: COMPETITIVE LANDSCAPE

    • 10.1. Introduction

    • 10.2. Top Winning Strategies

    • 10.3. Product Mapping Of Top 10 Player

    • 10.4. Competitive Dashboard

    • 10.5. Competitive Heatmap

    • 10.6. Top Player Positioning,2022

  • CHAPTER 11: COMPANY PROFILES

    • 11.1. Becton Dickinson And Company

      • 11.1.1. Company Overview

      • 11.1.2. Key Executives

      • 11.1.3. Company Snapshot

      • 11.1.4. Operating Business Segments

      • 11.1.5. Product Portfolio

      • 11.1.6. Business Performance

      • 11.1.7. Key Strategic Moves and Developments

    • 11.2. GE Healthcare

      • 11.2.1. Company Overview

      • 11.2.2. Key Executives

      • 11.2.3. Company Snapshot

      • 11.2.4. Operating Business Segments

      • 11.2.5. Product Portfolio

      • 11.2.6. Business Performance

      • 11.2.7. Key Strategic Moves and Developments

    • 11.3. Merck KgaA

      • 11.3.1. Company Overview

      • 11.3.2. Key Executives

      • 11.3.3. Company Snapshot

      • 11.3.4. Operating Business Segments

      • 11.3.5. Product Portfolio

      • 11.3.6. Business Performance

      • 11.3.7. Key Strategic Moves and Developments

    • 11.4. Thermo Fisher Scientific

      • 11.4.1. Company Overview

      • 11.4.2. Key Executives

      • 11.4.3. Company Snapshot

      • 11.4.4. Operating Business Segments

      • 11.4.5. Product Portfolio

      • 11.4.6. Business Performance

      • 11.4.7. Key Strategic Moves and Developments

    • 11.5. Bio-Rad Laboratories Inc

      • 11.5.1. Company Overview

      • 11.5.2. Key Executives

      • 11.5.3. Company Snapshot

      • 11.5.4. Operating Business Segments

      • 11.5.5. Product Portfolio

      • 11.5.6. Business Performance

      • 11.5.7. Key Strategic Moves and Developments

    • 11.6. Terumo BCT

      • 11.6.1. Company Overview

      • 11.6.2. Key Executives

      • 11.6.3. Company Snapshot

      • 11.6.4. Operating Business Segments

      • 11.6.5. Product Portfolio

      • 11.6.6. Business Performance

      • 11.6.7. Key Strategic Moves and Developments

    • 11.7. PluriSelect Life Science UG And Co. KG

      • 11.7.1. Company Overview

      • 11.7.2. Key Executives

      • 11.7.3. Company Snapshot

      • 11.7.4. Operating Business Segments

      • 11.7.5. Product Portfolio

      • 11.7.6. Business Performance

      • 11.7.7. Key Strategic Moves and Developments

    • 11.8. MiltenyiBiotec

      • 11.8.1. Company Overview

      • 11.8.2. Key Executives

      • 11.8.3. Company Snapshot

      • 11.8.4. Operating Business Segments

      • 11.8.5. Product Portfolio

      • 11.8.6. Business Performance

      • 11.8.7. Key Strategic Moves and Developments

    • 11.9. Beckman Coulter, Inc.

      • 11.9.1. Company Overview

      • 11.9.2. Key Executives

      • 11.9.3. Company Snapshot

      • 11.9.4. Operating Business Segments

      • 11.9.5. Product Portfolio

      • 11.9.6. Business Performance

      • 11.9.7. Key Strategic Moves and Developments

    • 11.10. STEMCELL Technologies Inc.

      • 11.10.1. Company Overview

      • 11.10.2. Key Executives

      • 11.10.3. Company Snapshot

      • 11.10.4. Operating Business Segments

      • 11.10.5. Product Portfolio

      • 11.10.6. Business Performance

      • 11.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CELL SEPARATION MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CELL SEPARATION MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CELL SEPARATION MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CELL SEPARATION MARKET, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CELL SEPARATION MARKET FOR HUMAN CELLS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CELL SEPARATION MARKET FOR ANIMAL CELLS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CELL SEPARATION MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CELL SEPARATION MARKET FOR CENTRIFUGATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL CELL SEPARATION MARKET FOR SURFACE MARKER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CELL SEPARATION MARKET FOR FILTRATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL CELL SEPARATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL CELL SEPARATION MARKET FOR RESEARCH LABORATORIES AND INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL CELL SEPARATION MARKET FOR BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL CELL SEPARATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL CELL SEPARATION MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL CELL SEPARATION MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL CELL SEPARATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL CELL SEPARATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL CELL SEPARATION MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA CELL SEPARATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. U.S. CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 27. U.S. CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 28. U.S. CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 29. U.S. CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. U.S. CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. CANADA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 32. CANADA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 33. CANADA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 34. CANADA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. CANADA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE CELL SEPARATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 45. EUROPE CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. FRANCE CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 48. FRANCE CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 49. FRANCE CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 50. FRANCE CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. FRANCE CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 53. GERMANY CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 54. GERMANY CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 55. GERMANY CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. GERMANY CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 57. ITALY CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 58. ITALY CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 59. ITALY CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 60. ITALY CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. ITALY CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. SPAIN CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 63. SPAIN CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 64. SPAIN CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 65. SPAIN CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SPAIN CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. UK CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 68. UK CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 69. UK CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 70. UK CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. UK CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 72. RUSSIA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 73. RUSSIA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 74. RUSSIA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 75. RUSSIA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. RUSSIA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. REST OF EUROPE CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 78. REST OF EUROPE CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 79. REST OF EUROPE CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 80. REST OF EUROPE CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. REST OF EUROPE CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. ASIA-PACIFIC CELL SEPARATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 83. ASIA-PACIFIC CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 84. ASIA-PACIFIC CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 85. ASIA-PACIFIC CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 86. ASIA-PACIFIC CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. ASIA-PACIFIC CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. CHINA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 89. CHINA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 90. CHINA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 91. CHINA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. CHINA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. JAPAN CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 94. JAPAN CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 95. JAPAN CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 96. JAPAN CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. JAPAN CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. INDIA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 99. INDIA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 100. INDIA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 101. INDIA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. INDIA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. SOUTH KOREA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 104. SOUTH KOREA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 105. SOUTH KOREA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH KOREA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH KOREA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. AUSTRALIA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 109. AUSTRALIA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 110. AUSTRALIA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 111. AUSTRALIA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 112. AUSTRALIA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 113. THAILAND CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 114. THAILAND CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 115. THAILAND CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 116. THAILAND CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 117. THAILAND CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 118. MALAYSIA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 119. MALAYSIA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 120. MALAYSIA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 121. MALAYSIA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 122. MALAYSIA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 123. INDONESIA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 124. INDONESIA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 125. INDONESIA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 126. INDONESIA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 127. INDONESIA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 128. REST OF ASIA PACIFIC CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 129. REST OF ASIA PACIFIC CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 130. REST OF ASIA PACIFIC CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 131. REST OF ASIA PACIFIC CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 132. REST OF ASIA PACIFIC CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. LAMEA CELL SEPARATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 134. LAMEA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 135. LAMEA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 136. LAMEA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 137. LAMEA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 138. LAMEA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 139. BRAZIL CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 140. BRAZIL CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 141. BRAZIL CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 142. BRAZIL CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 143. BRAZIL CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 144. SOUTH AFRICA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 145. SOUTH AFRICA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 146. SOUTH AFRICA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 147. SOUTH AFRICA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 148. SOUTH AFRICA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 149. SAUDI ARABIA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 150. SAUDI ARABIA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 151. SAUDI ARABIA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 152. SAUDI ARABIA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 153. SAUDI ARABIA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 154. UAE CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 155. UAE CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 156. UAE CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 157. UAE CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 158. UAE CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 159. ARGENTINA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 160. ARGENTINA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 161. ARGENTINA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 162. ARGENTINA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 163. ARGENTINA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 164. REST OF LAMEA CELL SEPARATION, BY PRODUCT TYPE, 2022-2032 ($MILLION)
  • TABLE 165. REST OF LAMEA CELL SEPARATION, BY CELL TYPE, 2022-2032 ($MILLION)
  • TABLE 166. REST OF LAMEA CELL SEPARATION, BY TECHNIQUE, 2022-2032 ($MILLION)
  • TABLE 167. REST OF LAMEA CELL SEPARATION, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 168. REST OF LAMEA CELL SEPARATION, BY END USER, 2022-2032 ($MILLION)
  • TABLE 169. BECTON DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 170. BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 171. BECTON DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 172. BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 173. BECTON DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 174. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 175. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 176. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 177. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 178. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 179. MERCK KGAA: KEY EXECUTIVES
  • TABLE 180. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 181. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 182. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 183. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 184. THERMO FISHER SCIENTIFIC: KEY EXECUTIVES
  • TABLE 185. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 186. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 187. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 188. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 189. BIO-RAD LABORATORIES INC: KEY EXECUTIVES
  • TABLE 190. BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT
  • TABLE 191. BIO-RAD LABORATORIES INC: OPERATING SEGMENTS
  • TABLE 192. BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO
  • TABLE 193. BIO-RAD LABORATORIES INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 194. TERUMO BCT: KEY EXECUTIVES
  • TABLE 195. TERUMO BCT: COMPANY SNAPSHOT
  • TABLE 196. TERUMO BCT: OPERATING SEGMENTS
  • TABLE 197. TERUMO BCT: PRODUCT PORTFOLIO
  • TABLE 198. TERUMO BCT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 199. PLURISELECT LIFE SCIENCE UG AND CO. KG: KEY EXECUTIVES
  • TABLE 200. PLURISELECT LIFE SCIENCE UG AND CO. KG: COMPANY SNAPSHOT
  • TABLE 201. PLURISELECT LIFE SCIENCE UG AND CO. KG: OPERATING SEGMENTS
  • TABLE 202. PLURISELECT LIFE SCIENCE UG AND CO. KG: PRODUCT PORTFOLIO
  • TABLE 203. PLURISELECT LIFE SCIENCE UG AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 204. MILTENYIBIOTEC: KEY EXECUTIVES
  • TABLE 205. MILTENYIBIOTEC: COMPANY SNAPSHOT
  • TABLE 206. MILTENYIBIOTEC: OPERATING SEGMENTS
  • TABLE 207. MILTENYIBIOTEC: PRODUCT PORTFOLIO
  • TABLE 208. MILTENYIBIOTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 209. BECKMAN COULTER, INC.: KEY EXECUTIVES
  • TABLE 210. BECKMAN COULTER, INC.: COMPANY SNAPSHOT
  • TABLE 211. BECKMAN COULTER, INC.: OPERATING SEGMENTS
  • TABLE 212. BECKMAN COULTER, INC.: PRODUCT PORTFOLIO
  • TABLE 213. BECKMAN COULTER, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 214. STEMCELL TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 215. STEMCELL TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 216. STEMCELL TECHNOLOGIES INC.: OPERATING SEGMENTS
  • TABLE 217. STEMCELL TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 218. STEMCELL TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL SEPARATION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CELL SEPARATION MARKET
  • FIGURE 3. SEGMENTATION CELL SEPARATION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CELL SEPARATION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCELL SEPARATION MARKET
  • FIGURE 11. CELL SEPARATION MARKET SEGMENTATION, BY BY PRODUCT TYPE
  • FIGURE 12. CELL SEPARATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CELL SEPARATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CELL SEPARATION MARKET SEGMENTATION, BY BY CELL TYPE
  • FIGURE 15. CELL SEPARATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CELL SEPARATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. CELL SEPARATION MARKET SEGMENTATION, BY BY TECHNIQUE
  • FIGURE 18. CELL SEPARATION MARKET FOR CENTRIFUGATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. CELL SEPARATION MARKET FOR SURFACE MARKER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. CELL SEPARATION MARKET FOR FILTRATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. CELL SEPARATION MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 22. CELL SEPARATION MARKET FOR RESEARCH LABORATORIES AND INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. CELL SEPARATION MARKET FOR BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. CELL SEPARATION MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. CELL SEPARATION MARKET SEGMENTATION, BY BY END USER
  • FIGURE 26. CELL SEPARATION MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. CELL SEPARATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. CELL SEPARATION MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 30. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 31. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 32. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 33. COMPETITIVE DASHBOARD
  • FIGURE 34. COMPETITIVE HEATMAP: CELL SEPARATION MARKET
  • FIGURE 35. Top player positioning, 2022
  • FIGURE 36. BECTON DICKINSON AND COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. GE HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. MERCK KGAA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. THERMO FISHER SCIENTIFIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. BIO-RAD LABORATORIES INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. BIO-RAD LABORATORIES INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. BIO-RAD LABORATORIES INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. TERUMO BCT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. TERUMO BCT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. TERUMO BCT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. PLURISELECT LIFE SCIENCE UG AND CO. KG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. PLURISELECT LIFE SCIENCE UG AND CO. KG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. PLURISELECT LIFE SCIENCE UG AND CO. KG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. MILTENYIBIOTEC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. MILTENYIBIOTEC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. MILTENYIBIOTEC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. BECKMAN COULTER, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. BECKMAN COULTER, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. BECKMAN COULTER, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. STEMCELL TECHNOLOGIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. STEMCELL TECHNOLOGIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. STEMCELL TECHNOLOGIES INC.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Cell Separation Market

Start reading.
This Report and over 67,069+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers